SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026958
Filing Date
2022-11-10
Accepted
2022-11-10 17:00:37
Documents
46
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q plxp20220930_10q.htm   iXBRL 10-Q 1032270
2 EXHIBIT 31.1 ex_439923.htm EX-31.1 13023
3 EXHIBIT 31.2 ex_439924.htm EX-31.2 13084
4 EXHIBIT 32.1 ex_439925.htm EX-32.1 7511
10 plxp20220930_10qimg001.jpg GRAPHIC 2715
  Complete submission text file 0001437749-22-026958.txt   4460960

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA plxp-20220930.xsd EX-101.SCH 35585
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plxp-20220930_cal.xml EX-101.CAL 34629
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plxp-20220930_def.xml EX-101.DEF 271998
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20220930_lab.xml EX-101.LAB 272116
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plxp-20220930_pre.xml EX-101.PRE 290544
40 EXTRACTED XBRL INSTANCE DOCUMENT plxp20220930_10q_htm.xml XML 578770
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 221378281
SIC: 2834 Pharmaceutical Preparations